Clinical Trials Browser

Phase 2/3 × Wilms Tumor × Decitabine × Clear all

NCT01809392 2013-03-12

Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Phase 2/3 Unknown

GenitourinaryMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Wilms Tumor, Leukemia, Myeloid, Acute